Research Studies and Clinical Trials Search
Results
Acute Liver Failure (ALF): A clinical trial of study drug (eATG or high dose methylprednisolone) compared to placebo (saline)
To participate in this study the participant must between 1 year and up to 18 years of age. This study is being done to learn if one medicine is better, the same, or worse for treating children with acute liver failure compared to another medicine and a placebo (a fake medicine).
To participate in this study the participant must between 1 year and up to 18 years of age. This study is being done to learn if one medicine is better, the same, or worse for treating children with acute liver failure compared to another medicine and a placebo (a fake medicine).
Alagille Syndrome (ALGS): A study on the long-term safety and effectiveness of Livmarli
This study is being done for children: • With a Alagille Syndrome (AlGS) diagnosis • Currently taken Livmarli. The purpose of this research study is to evaluate the long-term safety and outcomes of patients with Alagille Syndrome...
This study is being done for children: • With a Alagille Syndrome (AlGS) diagnosis • Currently taken Livmarli. The purpose of this research study is to evaluate the long-term safety and outcomes of patients with Alagille Syndrome (ALGS) who are prescribed Livmarli (maralixibat).
Alagille Syndrome: A clinical study of odevixibat in infants with Alagille syndrome.
This study is enrolling participants who: - Have a diagnosis of Alagille syndrome - Are <1 year of age...
This study is enrolling participants who: - Have a diagnosis of Alagille syndrome - Are <1 year of age Alagille syndrome is a rare disease that can cause problems in the liver. The purpose of this study is to see if odevixibat is safe, tolerable and effective in treating infants with Alagille syndrome.
Alagille Syndrome: A registry study of odevixibat in individuals with Alagille syndrome.
This study is enrolling participants who: - Have a diagnosis of Alagille syndrome - Currently taking odevixibat...
This study is enrolling participants who: - Have a diagnosis of Alagille syndrome - Currently taking odevixibat Alagille syndrome is a rare disease that can cause problems in the liver. The purpose of this study is to collect long-term data to see if odevixibat is safe and effective.
Hepatitis B Infection: A clinical study of tenofovir alafenamide in children and adolescents with long term hepatitis B infection
This study is enrolling participants who: - Are children who are 2 to less than 6 years of age - Have chronic (long term) hepatitis B virus infection...
This study is enrolling participants who: - Are children who are 2 to less than 6 years of age - Have chronic (long term) hepatitis B virus infection Chronic Hepatitis B is a viral liver infection. The purpose of this study is to see if Tenofovir Alafenamide is safe, tolerable, and effective in treating children and adolescents with hepatitis B virus infection.